No one likes the “B” word, but it’s worth asking whether we’re seeing one in large-cap biotech stocks right now.Source: ©iStock.com/AlexRathsAt first glance, it seems to be a legitimate question given how well the sector has performed in the past year. The iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) has gained nearly 70% since the low of mid-April 2014, and it […]
Related BIIBStifel Downgrades Biogen Amid Concerns Of Lack Of Upcoming Data, OvervaluationBenzinga’s Top #PreMarket LosersIs Biogen Stock Worth Considering Right Now?(Seeking Alpha)Related GILDGilead Shares Tumble On Drug Warning; Baird Says BuyBenzinga’s Top #PreMarket LosersSeeking Alpha’s Biotech Weekly: Biogen’s Plaque Attack, Amgen Or Gilead?, And More(Seeking Alpha)A number of biotech stocks were soaring in Friday’s premarket following positive news.Biogen Idec Inc […]
BloombergThe iShares Nasdaq Biotechnology ETF over 12 months
Stocks sold off on Thursday after a post-Fed rally on Wednesday.
But the Nasdaq still gained ground thanks to the biotech sector which gained about 2% on Thursday. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last month, Max Nisen at Quartz wrote that while everyone is focusing on […]
BloombergThe iShares Nasdaq Biotechnology ETF over 12 months
Stocks sold off on Thursday after a post-Fed rally on Wednesday.
But the Nasdaq still gained ground thanks to the biotech sector which gained about 2% on Thursday. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last month, Max Nisen at Quartz wrote that while everyone is focusing on […]
Billionaire Seth Klarman is a notorious investor who despite his uncoventional approaches always managed to achieve high returns. He founded Baupost Group in 1982 with around $30 million and since then the hedge fund grew to one of the biggest in the world and currently manages over $28 billion in assets. Mr. Klarman is very secretive about his strategies, which […]
Related ATHXMorning Market GainersWhy Investors Are Watching Athersys Ahead Of Stem Cell DataIn a recent report, analysts at Maxim Group discussed the biotechnology sector and gave their outlook for five names in the space. Here’s a rundown of what they had to say.Athersys, Inc. (NASDAQ: ATHX)Analysts believe that Athersys may have found a “sweet spot” for stroke treatment timing, as […]
More Charts
Remember when Federal Reserve Chair Janet Yellen said that social media and biotech stocks seemed pricey during a July 2014 testimony to Congress? “…Valuation metrics in some sectors do appear substantially stretched—particularly those for smaller firms in the social media and biotechnology industries, despite a notable downturn in equity prices for such firms early in the year,” she said.On Twitter, […]
View All3 Biotech Stocks That Could Pop in a HeartbeatBiotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months.Click to Enlarge And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For […]
The bull market turned six-years-old this week, which is pretty amazing. It’s been quite a ride. In that time, the Dow Jones Industrial Average has charged ahead more than 150%, the S&P 500 180% and Nasdaq 250%. One group that has been at the forefront of this bull market is biotech stocks.Source: FlickrIn fact, the past five years have been […]
When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of a […]
